Lv1
48 积分 2025-01-16 加入
Polysorbates 20 and 80 Used in the Formulation of Protein Biotherapeutics: Structure and Degradation Pathways
8天前
已完结
Impact of citrate on mitigating iron mediated polysorbate 80 degradation in biotherapeutic formulation placebos
8天前
已完结
HP-β-CD for the formulation of IgG and Ig-based biotherapeutics
9天前
已完结
Stabilizing Telitacicept with HPβCD: From formulation development to the elucidation of stabilization mechanisms
9天前
已完结
皖公网安备34019202002308
